One kilogram higher birth weight associated with a 10-20% reduced risk of heart disease later in life

Dr Rachel Huxley, lead author of the paper and Acting Director of Nutrition and Lifestyle at The George Institute said, "Although there was support for a small association between birth weight and an individual's future risk of heart disease, the relationship is not as strong as earlier studies have suggested.

Any effects that birth weight may have on heart disease are dwarfed by other risk factors operating in adult life, such as smoking and obesity."

Coronary heart disease is the leading cause of death in Australia, accounting for 38% of all deaths in 2002 and claiming the lives of more than one in three adults. The study suggests that one kilogram higher birth weight is associated with a 10-20% reduced risk of heart disease later in life, compared to smaller sized babies. However, researchers believe that interventions during the pregnancy period would have little effect on increasing the size of a baby.

"It has been suggested that strategies to increase early fetal growth could reduce the number of deaths from heart disease. However, interventions during pregnancy could really only increase birth weight by as much as 100g, which would translate in to a 1-2% lower risk of heart disease." Dr Huxley added.

"By comparison, interventions that focus on getting individuals to make lifestyle changes such as quitting smoking, exercising and eating sensibly would substantially lower the risk of heart disease and are more achievable than strategies aimed at increasing birth weight."

http://www.thegeorgeinstitute.org/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CRISPR-based therapy shown to be safe, effective for people with transthyretin amyloidosis